DDMP (2,4-diamino-5-(3′,4′-dichlorophenyl)-methylpyrimidine)
- 30 June 1980
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 7 (2), 95-112
- https://doi.org/10.1016/s0305-7372(80)80019-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Lethal and kinetic effects of DDMP (2,4-diamino-5-(3′,4′-dichlorophenyl)-6-methylpyrimidine)European Journal of Cancer (1965), 1979
- PROTECTION WITH SINGLE-DOSE FOLINIC ACID AGAINST BONE-MARROW DEPRESSION BY LONG-ACTING DIAMINOPYRIMIDINESThe Lancet, 1977
- The difference between “selective folinic acid protection” and “folinic acid rescue” in L5178Y cells cultureEuropean Journal of Cancer (1965), 1977
- Methotrexate resistance and uptake of DDMP by L5178Y cells: Selective protection with folinic acidEuropean Journal of Cancer (1965), 1975
- Methodichlorophen as anti-tumor drug.BMJ, 1975
- PYRIMETHAMINE IN PROPHYLAXIS OF MENINGEAL LEUKAEMIAThe Lancet, 1974
- PYRIMETHAMINE IN CENTRAL-NERVOUS-SYSTEM LEUKÆMIAThe Lancet, 1973
- Dihydrofolate reductase from Trypanosoma equiperdum. II. Inhibition by 2,4-diaminopyrimidines and related heterocyclesJournal of Medicinal Chemistry, 1969
- Daraprim in Treatment of MalariaBMJ, 1952
- Antimalarials as Antagonists of Purines and Pteroylglutamic AcidNature, 1949